Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00870441 · ClinicalTrials.gov registry record · Phase 1
Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers
A Phase 1 study, sponsored by Astellas Pharma.
- Terminated
- Registry status
- Phase 1
- Development phase
- 442
- Enrollment target
NCT00870441: Clinical Trial Phase 1 study, sponsored by Astellas Pharma.
NCT00870441 is a Phase 1 study that was terminated before completion, run by Astellas Pharma. The registered enrollment target is 442 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (637% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00870441, a Phase 1 study, was terminated before completion, sponsored by Astellas Pharma.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 442 participants
- Enrollment target
Study Summary
The objective of the study is to compare the safety of ASP2151 to valacyclovir and placebo in healthy male and female adult volunteers.
Interventions
- DRUG Placebo
- DRUG Valacyclovir
- DRUG ASP2151
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-04 |
| Phase | Phase 1 |
Why NCT00870441 stopped before completion
NCT00870441 is an interventional study that assigns participants to a tested intervention. The registered 442 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (637% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00870441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00870441 about?
NCT00870441 is a clinical study titled "Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers". The objective of the study is to compare the safety of ASP2151 to valacyclovir and placebo in healthy male and female adult volunteers.
What is the current status of trial NCT00870441?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 442 participants. The study started on 2009-03. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00870441?
The interventions under investigation include: Placebo (DRUG), Valacyclovir (DRUG), ASP2151 (DRUG).
Who is sponsoring clinical trial NCT00870441?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00870441's enrollment target sits among peer trials
442 59th of 2000 higher than 1,940 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
- NCT06659029 · 442 participants
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia